Nektar Therapeutics
NKTR
Revenue
23.49M
▲1.85M▲8.55%
3 Months ChangeAssets
343.33M
▼-52.68M▼-13.30%
3 Months ChangeLiabilities
263.65M
▼-5.66M▼-2.10%
3 Months ChangeFree Cash Flow
-48.05M
▲4.30M▲8.22%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-09
Form 10-Q
ID: 0000950170-24-094231
2024-08-08
Form 8-K
ID: 0001213900-24-066630
2024-06-06
Form 8-K
ID: 0001213900-24-050365
2024-05-10
Form 10-Q
ID: 0000950170-24-057312
2024-05-09
Form 8-K
ID: 0001213900-24-041325
2024-04-17
Form 8-K
ID: 0001213900-24-033856
2024-03-04
Form 8-K
ID: 0001213900-24-019557
2024-03-04
Form 8-K
ID: 0001193125-24-056966
2024-02-16
Form 8-K
ID: 0001213900-24-014968
2024-01-10
Form 8-K
ID: 0001213900-24-002718